Please ensure Javascript is enabled for purposes of website accessibility

CannTrust Holdings Doubles Sales as It Prepares to Move to the NYSE

By Sean Williams - Updated Nov 14, 2018 at 8:12PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was a trifecta for CannTrust in Q3, with impressive sales growth, a nominal profit, and news that it intends to list its shares in the United States.

The marijuana industry is budding before our eyes. This year alone, we've witnessed Vermont legalize adult-use pot entirely through the legislative process, seen the U.S. Food and Drug Administration approve the first cannabis-derived drug, and watched as two more states (Utah and Missouri) legalized medical marijuana, while Michigan expanded from medicinal pot to recreational use. And, of course, we stood in awe as Canada gave the green light to recreational pot.

We're also witnessing a transformation in the way investors analyze marijuana stocks. With Canada having legalized adult-use cannabis, operating results now matter considerably more than they ever have.

On Wednesday, following the close of trading, one of the major players in the Canadian cannabis space, CannTrust Holdings (CNTTQ 354.55%), released its third-quarter operating results. While still very early in the game, CannTrust delivered sizable sales growth, a nominal profit, and -- perhaps most interestingly -- signaled its likely move to the New York Stock Exchange

A tipped over bottle filled with dried cannabis buds lying atop a messy pile of cash bills.

Image source: Getty Images.

CannTrust Holdings Q3 results: The raw numbers

Metric  Q3 2018 Q3 2017 Year-Over-Year Growth (Decline)
Revenue *$12.59 million $6.14 million  105%
Net profit per share $0.00  $0.01 (100%)

Data source: CannTrust Holdings. *All data expressed in Canadian dollars. 

It was a solid quarter of growth for CannTrust, with total sales of 12.6 million Canadian dollars, an increase of 105% from the prior-year period. Canadian medical marijuana sales accounted for roughly CA$10 million, with the remainder being lower-margin wholesale revenue. It's worth noting that high-margin extracts accounted for CA$6.5 million of the company's total sales.

As for its bottom line, fair-value adjustments to the company's biological assets (i.e. cannabis plants) helped it, minus expenses, to generate CA$400,000 in net income, or $0.00 per share. Though down from a per-share profit of CA$0.01 in Q3 2017, it was nevertheless another profitable quarter.

What happened with CannTrust Holdings this quarter?

As you can imagine, given the lead-up to the Oct. 17 launch of recreational marijuana in Canada, most of CannTrust's focus has been on capacity expansion and its brands. Here are some of the highlights of what transpired during, and just after, the third quarter.

  • CannTrust entered into supply agreements with nine of Canada's 13 provinces and territories during the quarter. The more supply deals the company has, the less scrambling it has to do to find a home for its cannabis.
  • The company wound up launching a new recreational brand known as Peak Leaf during the third quarter. This is CannTrust's fourth adult-use brand, joining the previously launched Liiv, Synr.G, and Xscape.
  • CannTrust made its first shipment of cannabis oil to Denmark, signaling the company's push into overseas markets where medical marijuana and/or alternative pot products are legal.
  • Subsequent to the end of the quarter, CannTrust acquired 19.4 acres adjacent to its Niagara Greenhouse Facility that can be used for capacity expansion. The company is currently completing a 600,000-square-foot expansion of the Niagara Facility (450,000 square feet were completed and opened in late June).
  • On Oct. 1, CannTrust announced that co-founder Eric Paul had stepped down from his role as CEO (Paul was named board chairman), with Peter Aceto named the new CEO.
  • The company announced in its third-quarter operating results press release its intent to list its shares on the NYSE.
An indoor commercial hydroponic cannabis grow farm.

Image source: Getty Images.

What management had to say

With strong sales growth and CannTrust on track with its expansion projects, management was nothing but smiles in the third quarter. Eric Paul said: "We are extremely pleased with our Q3 results that are a testament to the success of this Company and the incredible progress that we have made in such a short period of time ... The appointment of Peter Aceto as CEO, a globally recognized and seasoned professional, will be the perfect compliment to our leadership team and will lead our Company into the next phase of our rapid growth."

The newly appointed Aceto had this to add about the company's prospective U.S. listing: "CannTrust has firmly established itself as one of the top licensed producers in Canada with a global platform rooted in science and innovation. A U.S. listing is a natural step forward in our evolution as we look to broaden our investor base and expand our business on an international scale."

Looking forward

So, what's next for CannTrust Holdings? Essentially, it's more of the same.

The company will be looking to complete its more than 1-million-square-foot Niagara Greenhouse Facility, which features hydroponic growing and moving containerized benches (known as the perpetual harvesting system). Management has previously stated that peak production will be in excess of 100,000 kilograms once Niagara is fully operational, and also taking into account its Vaughan Facility. Like its peers, it'll also be focusing on marketing, branding, and pushing into new markets.

What's important for investors to remember here is that there's no precedent for an industrialized country legalizing recreational marijuana, so this is just as much a learning experience for these pot companies as it is for Wall Street and investors. Though it's a rapidly growing industry, it'll take time to mature. This means investors need to take these quarterly earnings snapshots in stride and maintain a long-term view.

Based on what we've seen from CannTrust in the third quarter: So far, so good.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

CannTrust Holdings Inc. Stock Quote
CannTrust Holdings Inc.
CNTTQ
$0.05 (354.55%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
332%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/28/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.